2017 SPEAKERS:

 
 

 

Tudor Arvinte, President and Chief Executive Officer, Therapeomic Inc

Philip Ball, Market Access Manager, Napp Pharmaceuticals

Fereshteh Barei, Health Economist, LEGOS Paris Dauphine University

Dr Alain Beck, Senior Director, NBEs Analytical Chemistry, Centre d'Immunologie Pierre Fabre

Caroline Boulliat, Immunology, Oncology. Biosimilar Business Unit Head, Amgen Europe Gmbh

Joanna Brougher, Owner & Principal, BioPharma Law Group, PLLC, Biotech, Pharma and Medical Device IP and Corporate Co, BioPharma Law Group PLLC

Nicholas Cappuccino, Vice-President, Head of Quality and Scientific Affairs, Dr Reddy's Laboratories

Divya Chadha Manek, Head of Business Development (Commercial), National Institute for Health Research (NIHR)

Dan Cimpoeru, Board Member, European Cancer Patient Coalition

Anne Cook, Biologicals Quality Assessor, M.H.R.A.

Margaret Dolan, Regional Pharmacy Procurement Specialist, N.H.S.

Pieter Dylst, Senior Manager Market Access, Medicines for Europe

Catherine Evans, Business Development Manager for Biopharma, Bruker U.K. Ltd

Mathias Flume, Head of Drug Department, Kassenarztliche Vereinigung Westfalen-Lippe

Francois Xavier Frapaise MD, CMO, Merck Biosimilars

Uwe Gudat, Head of Safety, Biosimilars, Merck & Cie

Jatinder Harchowal, Jatinder Harchowal Chief Pharmacist / Clinical Director, Medicines Management & Clinical Support Services Business Unit, Royal Marsden NHS Foundation Trust

Ian Henshaw, Head of Business Operations, Biogen

Forrest Hu, General Manager of International Business, 3SBio Inc

Ruediger Jankowsky, Managing Director, Cinfa Biotech

Peter Jorgensen, Chief Executive Officer, I.G.L.

Parminder Kaur, CEO, RegPak BioPharma Consulting

Tarek Kilani, Former Head of Pharmacy & Continuing Medical Education Coordinator, Emirates French Hospital Llc

Martin Knight, Sr. Director, Strategy & Planning, Inflammation, Infectious Disease and General Medicine, Covance

Jenny Koppelkamm, Market Access Director, Takeda

Jenny Koppelkamm at World Biosimilar Congress

William Christopher Lamanna, Laboratory Head of Protein Characterization, Sandoz Inc

Adam Levysohn, Head of Global Market Access Biogen Biosimilars Business Unit, Biogen

Patrick Liu, Vice President of Global Biologics R&D and Head of Biologics, Assays and Technology, Teva Pharmaceuticals U.S.A.

Steinar Madsen, Medical Director, Norwegian Medicines Agency, Norway

Márcia Martini Bueno, Institucional Affairs Director, Libbs Pharmaceutica Ltda

Victor Lino Mendonça, VP Global Policy & Market Access Europe, Mylan

Gopalan Narayanan, VP, Complex Bio, Voisin Consulting Life Sciences (VCLS)

Cecil Nick, Vice President, PAREXEL

Ber Oomen, Executive Secretary and Treasurer, ‎European Specialist Nurses Organisations

Mareike Ostertag, Director Regulatory and Science Policy, Novartis Pharma AG

Michael Reilly, Executive Director, Alliance for Safe Biologic Medicines

Joaquin Rodrigo, Founder President, BIOSIM Spanish Association of Biosimilars

Dr Stacie Ropka, Partner, Axinn

Karsten Roth, Director Clinical Operations, Cinfa Biotech

Ingrid Schwarzenberger, Head of Global Regulatory Affairs Biopharmaceuticals, Sandoz Biopharmaceuticals Gmbh

Anjan Selz, Vice President – Head of Biosimilars EMEA, Lupin Europe Ltd

Tim Shea, Director, Sterne Kessler Goldstein And Fox Plc

George Stefanov, Marketing Operations Director Biologics, Europe, Mylan

Don Stewart, President and Chief Executive Officer, PlantForm Corporation

Don Stewart at World Biosimilar Congress

Gianluca Trifirò, Assistant Professor of Pharmacology, University of Messina

Florian Turk, Head of Global Payor Marketing, Sales and Relations, Sandoz

Jonathan Underhill, Associate Director for Medicines Evidence, NICE

Jonathan Underhill at World Biosimilar Congress

Manfred Weiler, Senior Vice President, Medical & Scientific Strategy, INC Research

Robert Wojciechowski, Director, Global Regulatory Consulting, INC Research/inVentiv Health

Elena Wolff-Holz, Elena Wolff-Holz, Chair, Biosimilar Medicinal Products Working Party (BMWP), Paul Ehrlich Institut

René Wuttke, Bioanalytical Principal Investigator, Global Bioanalytical Services, Celerion Inc.